Translocation (11;14) is a common cytogenetic abnormality in clonal plasma cells in monoclonal immunoglobulin deposition disease

Documenti analoghi

• Improved Outcomes of Myeloma Cast Nephropathy in Newly Diagnosed Multiple Myeloma With Modern Anti‐Myeloma Therapies
  di: Michael Sang Hughes, et al.
  Pubblicazione: (2025)
• Optical genome mapping improves detection and characterisation of cytogenetic abnormalities in non‐Hodgkin lymphomas
  di: Coura Fall, et al.
  Pubblicazione: (2026)
• Treatment of Refractory Monoclonal Immunoglobulin Deposition Disease With BCMA Bispecific Antibody
  di: Divaya Bhutani, et al.
  Pubblicazione: (2025)
• Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies
  di: Othman Salim Akhtar, et al.
  Pubblicazione: (2024)
• Enhancing risk stratification and treatment decision in multiple myeloma with SKY92 gene expression profiling in real‐world data
  di: Noa Biran, et al.
  Pubblicazione: (2025)